Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

3.571 -0.219 (-5.77%)
Streaming Delayed Price Updated: 1:54 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 89,105
Open 3.830
Bid (Size) 3.500 (1)
Ask (Size) 3.580 (1)
Prev. Close 3.790
Today's Range 3.409 - 3.830
52wk Range 1.305 - 12.30
Shares Outstanding 20,161,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga

Performance

YTD
-27.6%
-27.6%
1 Month
+79.5%
+79.5%
3 Month
+131.9%
+131.9%
6 Month
+70.1%
+70.1%
1 Year
-66.7%
-66.7%

More News

Read More
Wednesday's after hours session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
From CAMP4 Therapeutics
Via GlobeNewswire
Camp4 Reports Q2 Revenue Beats Estimates
Via The Motley Fool
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Sequans Appoints Jason W. Cohenour to Board of Directors
Via Newsfile
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
From CAMP4 Therapeutics
Via GlobeNewswire
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
Via Benzinga
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
From CAMP4 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
CAMP4 to Participate in Upcoming Investor Conferences
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From CAMP4 Therapeutics
Via GlobeNewswire
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
From CAMP4 Therapeutics
Via GlobeNewswire

Frequently Asked Questions

Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
The current price of CAMP4 Therapeutics Corporation - Common Stock is 3.571
When was CAMP4 Therapeutics Corporation - Common Stock last traded?
The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 10/10/25 01:54 PM ET
What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 72.00M
How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
CAMP4 Therapeutics Corporation - Common Stock has 72M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.